StonvexLoading…
StonvexCore line items from GBLI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $109.18M | $450.10M | $333.37M | $219.17M |
Operating Income | $5.51M | $33.30M | $24.10M | $8.04M |
Net Income | $4.25M | $25.33M | $18.88M | $6.36M |
EPS (Diluted) | $0.29 | $1.75 | $1.30 | $0.43 |
Total Assets | $1.68B | $1.72B | $1.73B | $1.72B |
Total Liabilities | $976.01M | $1.01B | $1.03B | $1.03B |
Cash & Equivalents | $34.83M | $65.54M | $75.36M | $67.34M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 14.41M | 14.26M | 14.22M | 14.16M |